Well Lead Med Co Ltd

Well Lead Med Co Ltd

603309 · SHG · Healthcare / Medical Instruments & Supplies

10.85CNY+0.01 (+0.09%)

Price History

Full chart

Market Stats

Previous Close10.84
Open10.92
Day Range10.79 – 10.94
52-Week Range10.53 – 16.42
Volume2.13M
Market Cap3.26B
P/E (TTM)55.90
Forward P/E0.00
EPS0.20
Dividend Yield8.94%
Beta-0.16
50-Day Avg11.40
200-Day Avg13.12

About

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, urethral and ureteral dilation, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation accessories, laryngeal masks, endobronchial and tracheostomy tubes, anesthesia breathing circuits and accessories, and nasopharyngeal and oropharyngeal airway products. The company also offers respiratory products, including oxygen and aerosol therapy products, and capnography mask and cannula products; drainage/suction/gastroenterology products, such as drainage systems, Yankauer handles, suction catheters, and stomach and feeding tubes; hemodialysis blood tubing set; home care products, including male external catheter and convicath intermittent catheter; and ambulatory infusion pump for pain management. Well Lead Medical Co., Ltd. was founded in 1998 and is based in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Guangyuan Han
  • Employees2.85K
  • Headquarters47 Guomao Avenue South, Guangzhou, China, 511434, China
  • Websitehttps://www.wellead.com

Leadership

  • Mr. Guangyuan HanVice Chairman & GM · b. 1964
  • Ms. Yimin ZhuCFO & Accounting Supervisor · b. 1980
  • Ms. Yungui ChenDeputy General Manager · b. 1975
  • Mr. Song Feng DuanDeputy GM & Director · b. 1968
  • Mr. Bin ChenDeputy GM & Board Secretary · b. 1980

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue348.24M387.22M437.17M496.41M548.87M515.42M629.89M745.83M993.81M1.13B1.12B1.36B1.39B1.51B1.63B
Growth (%)-+11.20%+12.90%+13.55%+10.57%-6.09%+22.21%+18.41%+33.25%+13.77%-1.07%+21.88%+1.79%+8.76%+8.07%
Cost of Revenue236.28M250.02M277.35M317.55M365.40M323.30M415.98M483.90M558.30M637.18M646.82M784.98M762.64M846.46M901.44M
Gross Profit111.95M137.20M159.82M178.87M183.47M192.12M213.91M261.93M435.51M493.49M471.76M578.37M625.10M662.88M729.74M
Gross Margin32.15%35.43%36.56%36.03%33.43%37.28%33.96%35.12%43.82%43.65%42.17%42.42%45.04%43.92%44.74%
Operating Expense53.15M68.48M83.14M92.72M86.10M106.96M141.58M192.31M288.66M295.23M329.04M371.72M386.26M397.38M425.13M
Operating Income58.80M68.71M76.68M86.15M97.37M85.17M72.34M69.63M146.85M198.27M142.72M206.65M238.84M265.50M304.60M
Operating Margin16.89%17.75%17.54%17.35%17.74%16.52%11.48%9.34%14.78%17.54%12.76%15.16%17.21%17.59%18.67%
EBITDA60.71M82.04M91.48M105.39M118.14M114.13M102.15M100.61M204.51M249.10M198.03M269.85M309.59M338.29M239.20M
EBITDA Margin17.43%21.19%20.92%21.23%21.52%22.14%16.22%13.49%20.58%22.03%17.70%19.79%22.31%22.41%14.66%
Net Income47.92M55.61M63.59M67.82M91.32M79.25M64.56M65.40M121.14M153.11M106.09M166.57M192.49M219.39M76.33M
Net Income Margin13.76%14.36%14.54%13.66%16.64%15.38%10.25%8.77%12.19%13.54%9.48%12.22%13.87%14.54%4.68%
R&D-12.94M16.38M4.58M20.32M23.47M12.00M16.74M42.25M55.31M55.03M82.07M94.92M111.11M115.66M
R&D as % of Total Revenue-3.34%3.75%0.92%3.70%4.55%1.91%2.24%4.25%4.89%4.92%6.02%6.84%7.36%7.09%
Interest Expense2.14M3.29M1.95M3.99M1.22M469.94K571.90K4.53M14.20M11.02M9.31M8.31M9.61M12.85M18.19M
Interest Expense % of Total Revenue0.61%0.85%0.45%0.80%0.22%0.09%0.09%0.61%1.43%0.97%0.83%0.61%0.69%0.85%1.12%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets365.30M409.14M473.51M525.80M881.08M972.68M1.01B1.41B1.46B1.49B2.13B2.38B2.61B2.84B2.86B
Total Liabilities171.89M159.77M171.15M155.62M102.43M109.37M110.63M474.41M419.35M344.83M540.87M643.85M768.37M937.61M1.08B
Total Equity193.41M248.83M301.92M369.74M778.20M857.45M892.01M927.41M1.03B1.13B1.58B1.72B1.82B1.88B1.76B
Cash59.97M60.65M72.48M93.91M98.02M111.42M134.59M149.07M172.62M161.85M604.58M393.02M302.87M287.64M253.96M
Total Debt95.00M77.25M65.25M45.00M---257.50M225.34M134.17M240.67M260.00M376.92M467.26M-
Net Debt35.03M16.60M-7.23M-48.91M-98.02M-111.42M-134.59M108.43M52.72M-27.68M-363.92M-133.03M74.04M179.62M257.70M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow44.08M83.23M72.85M107.34M81.47M85.35M74.34M89.89M178.79M228.44M187.28M391.13M233.51M306.26M330.26M
Investing Cash Flow-63.12M-48.34M-42.99M-54.14M-353.93M-82.12M-22.39M-314.61M-92.02M-95.75M-156.34M-559.93M-335.45M-255.65M-
Financing Cash Flow56.28M-34.52M-16.03M-34.29M276.24M6.00M-23.50M238.34M-64.21M-137.90M413.88M-46.91M11.66M-67.71M-
Capital Expenditure44.77M46.92M43.06M51.49M36.98M68.93M71.12M78.66M112.54M92.49M109.28M181.38M357.89M315.73M206.15M
Free Cash Flow-692.85K36.31M29.79M55.86M44.48M16.41M3.23M11.23M66.26M135.96M78.00M209.75M-135.38M-9.47M124.11M
Dividends Paid82.90M19.22M4.03M14.04M30.66M30.00M30.00M30.00M20.00M40.00M52.00M39.58M106.84M155.60M159.20M
FCF to OCF-1.57%43.63%40.89%52.04%54.60%19.23%4.34%12.49%37.06%59.51%41.65%53.63%-57.97%-3.09%37.58%
Dividend Paid to FCF-11964.99%52.93%13.53%25.14%68.92%182.76%930.20%267.24%30.19%29.42%66.66%18.87%-78.92%-1643.12%128.27%

Earnings

Report DateApr 28, 2015Jun 30, 2015Oct 26, 2015Dec 31, 2015Apr 25, 2016Aug 16, 2016Oct 27, 2016Dec 31, 2016Apr 10, 2017Aug 17, 2017Oct 23, 2017Mar 29, 2018Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jul 29, 2019Oct 28, 2019Dec 31, 2019Apr 28, 2020Jul 30, 2020Oct 27, 2020Dec 31, 2020Apr 26, 2021Aug 19, 2021Oct 21, 2021Dec 31, 2021Apr 22, 2022Jul 28, 2022Oct 19, 2022Dec 31, 2022Apr 19, 2023Aug 8, 2023Dec 31, 2025Apr 22, 2026
EPS Estimate----------------------------------0.210.21
EPS Actual0.060.110.100.080.050.080.100.070.060.100.050.050.020.070.070.090.080.200.130.060.030.340.160.050.090.090.130.090.090.150.190.100.100.14-0.40-0.40
Surprise-----------------------------------290.48%-290.48%
TimingPre-market-After-hours-After-hoursPre-marketAfter-hours-After-hoursPre-marketAfter-hoursAfter-hours-----Pre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-market-Pre-marketAfter-hours-After-hours

Key Statistics & Ratios

Market Cap3.26B
Enterprise Value3.39B
Trailing P/E55.90
Forward P/E0.00
Price / Sales1.97
Price / Book1.81
EPS0.20
Book Value6.09
Revenue (TTM)1.65B
Gross Profit (TTM)716.98M
EBITDA346.20M
Profit Margin3.46%
Operating Margin14.30%
Return on Equity3.72%
Return on Assets6.10%
Shares Outstanding291.87M
Shares Float142.57M
Beta-0.16
Dividend Yield8.94%
Dividend Rate1.00
Payout Ratio250.00%

Dividends

20231×
0.34May 29, 2023
20221×
0.14May 26, 2022
20211×
0.20May 27, 2021
20201×
0.20May 25, 2020
20191×
0.08May 30, 2019
20181×
0.12Jun 12, 2018
20171×
0.12Jun 9, 2017
20151×
0.23Sep 25, 2015

Stock Splits

  • May 25, 202013:10
  • Sep 25, 20152:1